首页> 外国专利> Method of determination of the activation of the system or of the blood coagulation system in the blood plasma fibrinolytic

Method of determination of the activation of the system or of the blood coagulation system in the blood plasma fibrinolytic

机译:确定血浆纤溶蛋白中系统或血液凝固系统激活的方法

摘要

A thrombosis test is based on the presence of specific, newly-found, enzyme-inhibitor complexes (such as plasmin-antiplasmin, plasmin- alpha 2-macroglobulin, thrombin-antithrombin-III) in blood samples having an activated blood coagulation and/or fibrinolytic system. The test is immunochemical and uses a purified antiserum which has been generated against the enzyme-inhibitor complex. The antiserum is purified by incubating the antiserum with plasminogen and fresh blood plasma and isolating a gamma globulin fraction containing antibodies specific to the enzyme-inhibitor complex. A reagent for the test is prepared by contacting a blood cell suspension or a latex of particles of synthetic resin with the purified antiserum to obtain a suspension or latex in which antibodies from the antiserum are present on the surface of the cells or particles.
机译:血栓形成测试是基于血液样本中具有活化的凝血功能和/或/纤溶系统。该测试是免疫化学的,使用针对酶抑制剂复合物的纯化抗血清。通过将抗血清与纤溶酶原和新鲜血浆一起温育,并分离出含有对酶抑制剂复合物具有特异性的抗体的γ-球蛋白级分,可以纯化抗血清。通过使血细胞悬浮液或合成树脂颗粒的胶乳与纯化的抗血清接触以获得悬浮液或胶乳,其中来自抗血清的抗体存在于细胞或颗粒的表面上来制备测试用试剂。

著录项

  • 公开/公告号FR2326705A1

    专利类型

  • 公开/公告日1977-04-29

    原文格式PDF

  • 申请/专利号FR19760028057

  • 发明设计人

    申请日1976-09-17

  • 分类号G01N33/16;

  • 国家 FR

  • 入库时间 2022-08-22 23:47:47

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号